M

Your submission is now a Draft.

Once it's ready, please submit your draft for review by our team of Community Moderators. Thank you!

You have been invited to co-author this question.

When it is ready, the author will submit it for review by Community Moderators. Thanks for helping!

Pending

This question now needs to be reviewed by Community Moderators.

We have high standards for question quality. We also favor questions on our core topic areas or that we otherwise judge valuable. We may not publish questions that are not a good fit.

If your question has not received attention within a week, or is otherwise pressing, you may request review by tagging @moderators in a comment.

You have been invited to co-author this question.

It now needs to be approved by Community Moderators. Thanks for helping!

{{qctrl.question.title}}

{{qctrl.question.predictionCount() | abbrNumber}} predictions
{{"myPredictionLabel" | translate}}:  
{{ qctrl.question.resolutionString() }}
{{qctrl.question.predictionCount() | abbrNumber}} predictions
My score: {{qctrl.question.player_log_score | logScorePrecision}}
Created by: christian and
co-authors , {{coauthor.username}}

Make a Prediction

Prediction

This question supports and is linked to a fortified essay on the future of nanotechnology by Physical Chemist Kevin Ausman. Click here to read the full essay. There is a related question, whether nanoparticle-enabled cancer therapy will be approved by 2031, here.

Inorganic nanoparticles are small collections of a few thousand to a few billion atoms, typically ranging from 1 to 100 nm in diameter. They have many peculiar chemical and physical properties, which make them attractive for designing therapies.

An example of such technology is called Aurolase Therapy, and has been in development for two decades. It's now in pilot studies in humans with early results giving reason for optimism.